1-9 of 9
Ernesto Di Francesco
Close
Sort by
Journal Articles

Effect Of Heterozygous JAK2 V617F On Thrombotic Risk In Patients With Polycythemia Vera: Measuring The Uncertain

Emma Cacciola, MD, Antonino Cipolla, Ernesto Di Francesco, Elisa Seria, Maria Torre, Rossella Rosari Cacciola
Journal: Blood
Blood (2013) 122 (21): 5251.
https://doi.org/10.1182/blood.V122.21.5251.5251
Published: 2013
Journal Articles

Interleukin-15 Levels in Patients with Essential Thrombocythemia

Emma Cacciola, Ernesto Di Francesco, Antonino Cipolla, Carmen Ferlito, Francesca Pezzella, Elisa Seria, Rossella Rosari Cacciola
Journal: Blood
Blood (2012) 120 (21): 5071.
https://doi.org/10.1182/blood.V120.21.5071.5071
Published: 2012
Journal Articles

Inflammation and Thrombosis In Essential Thrombocythemia

Rossella Cacciola, M.D., Ernesto Di Francesco, Carmen Ferlito, Francesca Pezzella, Elisa Seria, Antonino Cipolla, Emma Cacciola, M.D.
Journal: Blood
Blood (2011) 118 (21): 5175.
https://doi.org/10.1182/blood.V118.21.5175.5175
Published: 2011
Journal Articles

Fibroblast Growth Factor-2 and Lactate Dehydrogenase Levels in Patients with Essential Thrombocythemia Treated with Anagrelide.

Rossella R Cacciola, Assistant, Professor, Ernesto Di Francesco, PhD, Francesca Pezzella, Emma Cacciola, MD
Journal: Blood
Blood (2009) 114 (22): 4981.
https://doi.org/10.1182/blood.V114.22.4981.4981
Published: 2009
Journal Articles

JAK2V617F Mutation Status and Thrombosis in Essential Thrombocythemia

Emma Cacciola, Ernesto Di Francesco, PhD, Francesca Pezzella, Daniele Tibullo, Rossella R Cacciola
Journal: Blood
Blood (2008) 112 (11): 5262.
https://doi.org/10.1182/blood.V112.11.5262.5262
Published: 2008
Journal Articles

Efficacy of Anagrelide Compared with Hydroxyurea in Patients with Essential Thrombocythemia.

Rossella Rosari Cacciola, Ernesto Di Francesco, Francesca Pezzella, Daniele Tibullo, Rosario Giustolisi, Emma Cacciola
Journal: Blood
Blood (2007) 110 (11): 4634.
https://doi.org/10.1182/blood.V110.11.4634.4634
Published: 2007
Journal Articles

Tissue Plasminogen Activator (t-PA) and Plasminogen Activator Inhibitor-1 (PAI-1) in Essential Thrombocythemia and Polycythemia Vera and Thrombotic Complications.

Rossella R. Cacciola, MD, PhD, Ernesto Di Francesco, Rosario Giustolisi, MD, Emma Cacciola, MD
Journal: Blood
Blood (2006) 108 (11): 4879.
https://doi.org/10.1182/blood.V108.11.4879.4879
Published: 2006
Journal Articles

Rituximab in Chronic Relapsing Acquired Thrombotic Thrombocytopenic Purpura.

Gaetano Giuffrida, MD, Amalia Figuera, MD, Rocca Cingari, MD, Santo Maccarone, MD, Ernesto Di Francesco, PhD, Rosario Giustolisi, MD
Journal: Blood
Blood (2005) 106 (11): 3997.
https://doi.org/10.1182/blood.V106.11.3997.3997
Published: 2005
Journal Articles

Inherited Thrombophilias in Essential Thrombocythemia and Polycythemia Vera Are Not an Additional Risk Factor for Thrombosis.

Emma Cacciola, Antonio Cipolla, Ernesto Di Francesco, Rosario Giustolisi, Rossella R. Cacciola
Journal: Blood
Blood (2005) 106 (11): 4934.
https://doi.org/10.1182/blood.V106.11.4934.4934
Published: 2005